
Opinion|Videos|April 14, 2025
Evidence Supporting 2024 Guidance for Lp(a) Testing
Experts discuss the evidence supporting the National Lipid Association’s (NLA) recommendation for universal lipoprotein(a) (Lp[a]) measurement and evaluate how compelling this evidence is from a clinical perspective.
Advertisement
Video content above is prompted by the following:
- What evidence supported the NLA’s recommendation?
- How compelling is this evidence from a clinical perspective?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA to Accept Deidentified Real-World Evidence for Select Medical Device Applications
2
FDA Approves Fam-Trastuzumab Deruxtecan-Nxki for Metastatic HER2-Positive Breast Cancer
3
ACA Subsidy Expiration Raises Concerns for Behavioral Health Access and ED Strain
4
HIV in 2025 Defined by Challenges Throughout the Year, Despite Some Advances
5









































